Create Alert
Watchlist

Ajanta Pharma

₹0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Fundamentals

Market Cap₹32,331Cr
ROE25.39%
P/E Ratio(TTM)34.76
EPS(TTM)74.44
P/B Ratio8.53
Dividend Yield1.09%
Industry P/E34.72
Book Value303.37
Debt to Equity0.01
Face Value2
Understand Fundamentals

Financials

*All values are in Rs. Cr
No Graph Data To Display
Quarterly
Yearly

About Ajanta Pharma

Ajanta Pharma Limited is an India-based specialty pharmaceutical company. The Company provides a comprehensive range of specialty branded generic products targeting a broad range of chronic and acute therapies. The Company is engaged in the manufacturing and sale of branded generic and generic pharmaceutical products. It has a wide range of therapeutic segments, such as cardiology, anti-diabetes, ophthalmology, dermatology, antibiotic, anti-malarial, pain, respiratory, gynecology, pediatric and general health products. Its branded generics business is spread across India, the rest of Asia, and Africa. Its business also consists of two verticals: United States generics and institutional business in Africa. Its ophthalmology products include Bimat (anti glaucoma), Nepaflam (anti-inflammatory), Softdrops (lubricant), and Olopat (anti-allergic). The Company's cardiology products include MET XL, Atorfit CV, Antihypertensive Cinod, Rosutor Gold, Dapalex and Vilatin.;
Parent OrganisationAjanta Pharma Limited
Managing DirectorMr. Rajesh Agrawal
NSE SymbolAJANTPHARM

Shareholding Pattern

Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Promoters
66.26%
Mutual Funds
14.72%
Foreign Institutions
8.86%
Retail And Others
7.38%
Other Domestic Institutions
2.78%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Torrent Pharmaceuticals
NA
(0.00%)
61.02
Gland Pharma
NA
(0.00%)
39.97
Eris Lifesciences
NA
(0.00%)
60.20
Sai Life Sciences
NA
(0.00%)
72.89